The "Mikidney" smartphone app pilot study: Empowering patients with Chronic Kidney Disease.
Chronic kidney disease
Empowerment
Self-management/self-care
Smartphone app
mHealth
Journal
Journal of renal care
ISSN: 1755-6686
Titre abrégé: J Ren Care
Pays: United States
ID NLM: 101392167
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
14
11
2018
revised:
05
03
2019
accepted:
17
03
2019
pubmed:
30
7
2019
medline:
9
6
2020
entrez:
30
7
2019
Statut:
ppublish
Résumé
Successful management of chronic kidney disease (CKD) depends on patients' self-management efforts. Mobile health applications can empower patients with CKD to manage their own condition. We developed, with patient involvement, the MiKidney smartphone application. Evaluate the MiKidney app as an aid to empowering patients with CKD to become more engaged in the management of their condition. Pilot single group pre- and post-test intervention study. Renal clinic of an urban University Hospital in Ireland. Aged over 18 years with CKD and able to use a smartphone. Sample size based on expression of interest and availability of free smartphones (n = 23); three patients withdrew prior to T3 data collection (n = 20). Data were collected at T1 (baseline), T2 (week 6) and when exiting the study (T3, 12 weeks) on physical activity, body measurements and blood parameters. Information on app usage and patient satisfaction collected at T2 and T3. There was significant improvement in the six-minute walking test (p = 0.02), total cholesterol (p = 0.023) and LDL cholesterol (p = 0.005) serum levels and a significant decrease in waist circumstance (p = 0.00) and body fat (p = 0.01) measurements. Eighteen participants found the MiKidney app easy to navigate. The MiKidney study highlights the viability and usability of the MiKidney app. It has the potential to empower and motivate patients to understand and self-manage their condition by providing them with the necessary information on renal diet and symptom management. Additionally, tools such as exercise tracker and reminder alerts are available on a readily accessible user-friendly platform.
Sections du résumé
BACKGROUND
BACKGROUND
Successful management of chronic kidney disease (CKD) depends on patients' self-management efforts. Mobile health applications can empower patients with CKD to manage their own condition. We developed, with patient involvement, the MiKidney smartphone application.
AIM
OBJECTIVE
Evaluate the MiKidney app as an aid to empowering patients with CKD to become more engaged in the management of their condition.
DESIGN
METHODS
Pilot single group pre- and post-test intervention study.
SETTING
METHODS
Renal clinic of an urban University Hospital in Ireland.
PATIENTS
METHODS
Aged over 18 years with CKD and able to use a smartphone. Sample size based on expression of interest and availability of free smartphones (n = 23); three patients withdrew prior to T3 data collection (n = 20).
MEASUREMENTS
METHODS
Data were collected at T1 (baseline), T2 (week 6) and when exiting the study (T3, 12 weeks) on physical activity, body measurements and blood parameters. Information on app usage and patient satisfaction collected at T2 and T3.
RESULTS
RESULTS
There was significant improvement in the six-minute walking test (p = 0.02), total cholesterol (p = 0.023) and LDL cholesterol (p = 0.005) serum levels and a significant decrease in waist circumstance (p = 0.00) and body fat (p = 0.01) measurements. Eighteen participants found the MiKidney app easy to navigate.
CONCLUSION
CONCLUSIONS
The MiKidney study highlights the viability and usability of the MiKidney app. It has the potential to empower and motivate patients to understand and self-manage their condition by providing them with the necessary information on renal diet and symptom management. Additionally, tools such as exercise tracker and reminder alerts are available on a readily accessible user-friendly platform.
Types de publication
Journal Article
Langues
eng
Pagination
133-140Subventions
Organisme : Royal City of Dublin Hospital Trust
ID : 14021/188
Informations de copyright
© 2019 European Dialysis and Transplant Nurses Association/European Renal Care Association.